Product Code: ETC4471649 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Cardiac marker testing is a crucial component of the Indonesian healthcare system, given the high prevalence of cardiovascular diseases in the population. The market comprises a range of diagnostic tests, such as troponin, B-type natriuretic peptide (BNP), and creatine kinase-MB (CK-MB), aimed at assessing and diagnosing heart-related conditions.
Cardiac marker testing is growing in importance as it helps diagnose heart conditions. The increasing prevalence of cardiovascular diseases and the need for timely and accurate diagnosis are key market drivers.
The cardiac marker testing market in Indonesia faces various challenges. One of the key concerns is the need for standardized protocols and guidelines for cardiac marker testing across healthcare facilities. Ensuring the accuracy and consistency of cardiac marker results is crucial for timely diagnosis and treatment of cardiac conditions. Additionally, there may be challenges related to the availability of a wide range of cardiac marker tests, which are essential for comprehensive cardiac assessment.
The cardiac marker testing market in Indonesia was impacted as resources were diverted to address the pandemic. Routine cardiac marker testing faced a temporary decline as healthcare facilities prioritized COVID-19 testing and care. However, the importance of cardiac health remained, and the market adjusted by emphasizing remote monitoring and telehealth solutions to manage cardiac patients during the pandemic.
The Indonesia Cardiac Marker Testing market features major players such as Bio-Rad Laboratories, Beckman Coulter, and Siemens Healthineers. These companies offer a wide array of cardiac marker testing solutions for early detection and management of cardiovascular diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Cardiac Marker Testing Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Indonesia Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Indonesia Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Indonesia Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Indonesia Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Indonesia Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Indonesia Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Indonesia |
4.2.2 Growing awareness about early detection and diagnosis of heart conditions |
4.2.3 Technological advancements in cardiac marker testing methods |
4.3 Market Restraints |
4.3.1 High cost associated with cardiac marker testing procedures |
4.3.2 Limited access to healthcare facilities in remote areas of Indonesia |
4.3.3 Lack of skilled healthcare professionals for conducting cardiac marker tests |
5 Indonesia Cardiac Marker Testing Market Trends |
6 Indonesia Cardiac Marker Testing Market, By Types |
6.1 Indonesia Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Indonesia Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Indonesia Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Indonesia Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Indonesia Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Indonesia Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Indonesia Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Indonesia Cardiac Marker Testing Market Export to Major Countries |
7.2 Indonesia Cardiac Marker Testing Market Imports from Major Countries |
8 Indonesia Cardiac Marker Testing Market Key Performance Indicators |
8.1 Average turnaround time for cardiac marker testing |
8.2 Adoption rate of new cardiac marker testing technologies |
8.3 Percentage of population screened for cardiac markers on an annual basis. |
9 Indonesia Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Indonesia Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Indonesia Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Indonesia Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Indonesia Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Indonesia Cardiac Marker Testing Market - Competitive Landscape |
10.1 Indonesia Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |